Jcog0404
Webjcog0404：進行大腸がんに対する腹腔鏡下手術と開腹手術の根治性に 関するランダム化比較試験. 2016. 年. 9月20日 研究代表者：大分大学. 北野 正剛 研究事務局：大分大学. 猪 … Web4 apr 2024 · The Japan Clinical Oncology Group (JCOG) conducted a randomized controlled trial, JCOG0404, to confirm the non-inferiority of laparoscopic surgery (LAP) to open surgery (OP) with D3 dissection for …
Jcog0404
Did you know?
WebMethods: This analysis included patients from 4 randomized controlled trials (RCTs) conducted by the Japan Clinical Oncology Group (JCOG): JCOG0205, JCOG0404, … WebThis study evaluated institutional variation in survival and postoperative complications using data from JCOG0404 comparing laparoscopic colectomy (LAP) with open colectomy (OP).
Web8 lug 2005 · INTRODUCTION. The benefits of laparoscopic surgery (LAP) in comparison with open surgery (OPEN) have been suggested with respect to decreased morbidity, decreased pain, faster recovery and shorter hospital stay (1 – 4).However, the long-term survival of LAP for colorectal cancer is still unclear, especially for advanced colorectal … Web22 lug 2024 · The rate of IC acquisition for the JCOG0404 trial, which was performed by the same clinical oncological group that performed the present JCOG1107 trial, was 62% . Possible reasons were considered to be the differences between curative and non-curative resection and gradually increasing reports supporting the laparoscopic procedure for …
Web4 apr 2024 · The Japan Clinical Oncology Group (JCOG) conducted a randomized controlled trial, JCOG0404, to confirm the non-inferiority of laparoscopic surgery (LAP) to … WebJCOG0404試験）は横行結腸・下行結腸癌を除く cStage Ⅱ/Ⅲの進行結腸癌（Rs含む）における開腹 手術（以下，Op）に対するLapの非劣性を見たRCT であったが，結果は主 …
WebKitano, Seigo ; Inomata, Masafumi ; Mizusawa, Junki et al. / Survival outcomes following laparoscopic versus open D3 dissection for stage II or III colon cancer (JCOG0404) : a phase 3, randomised controlled trial. In: The Lancet Gastroenterology and Hepatology. 2024 ; Vol. 2, No. 4. pp. 261-268.
WebJCOG9803. Feasibility. A feasibility study of Quality-of-life (QOL) evaluation in a randomized phase III trial of doxorubicin (A)/cyclophosphamide (C) (AC), docetaxel (D), and alternating AC and D (AC-D) as front-line chemotherapy for metastatic breast cancer (MBC) (JCOG9802/BC 4-CAD) Closed. ascott kuala lumpur hi teaWeb26 mar 2024 · JCOG0404 was a multi-institutional trial to confirm the non-inferiority of laparoscopic surgery compared to open surgery for clinical stage II or III colorectal … ascott kuningan jakarta agodaWebA total of 1057 patients were randomized (OP 528, LAP 529) from October 2004 through March 2009. Conversion to OS was only needed for 29 patients (5.4%) in the LS arm. The low conversion rate indicated a high quality of surgeons in this study group. JCOG0404 and results of other large clinical trials are shown in Table 1. ascott kuningan jakartahttp://www.jcog.jp/document/s_0404.pdf ascott kuala lumpur sentralWeb29 gen 2024 · Eligibility criteria in JCOG0404 included histologically proven colon cancer; T3 or deeper lesion without involvement of other organs; N0-2 and M0. D3 lymph node dissection with or without preserving LCA was identified according to the photographs of the resected field collected for central surgical review in JCOG0404. ascott kuningan jakarta teleponWeb1 ago 2014 · JCOG0404 is a randomized controlled trial to evaluate the short- and long-term outcomes of OP and LAP surgery for clinical Stage II/III colon cancer (UMIN-CTR, … ascott kuningan jakarta booking.comWeb25 apr 2024 · Purpose To compare the short-term outcomes of conventional open colectomy with those of laparoscopic colectomy for colon cancer. Methods We retrieved data between January 2014 and March 2016 from the Diagnosis Procedure Combination database. A total of 69,418 patients who underwent colectomy for colon cancer were analyzed from … ascott kuningan apartment